GLP-1 and GIP/GLP-1 receptor agonists require refrigeration between 36F and 46F (2C to 8C) until first use
Both can route either brand-name FDA-approved products or compounded semaglutide and tirzepatide through licensed compounding pharmacies, depending on eligibility and availability
Severe reactions are rare but can occur
Portal-peripheral insulin mismatch in T1D: subcutaneous insulin produces peripheral hyperinsulinaemia roughly four to eight times physiological
INGREDIENTS: Aqua (Water), Paraffinum Liquidum (Mineral Oil), Cetearyl Alcohol, Petrolatum, Synthetic Wax, Polysorbate 60, Glycerin, Sorbitan Stearate, Dimethicone, Caprylic/Capric Triglyceride, Glutathione, Ascorbyl Tetraisopalmitate, Diacetyl Boldine, PEG-40 Hydrogenated Castor Oil, Sodium Levulinate, PPG-8-Ceteth-20, PPG-4-Ceteth-20, Butylene Glycol, Glyceryl Stearate, PEG-100 Stearate, Palmitic Acid, Stearic Acid, Levulinic Acid, Carbomer, Xanthan Gum, Disodium EDTA, Tocopherol, Triethanolamine, Citric Acid, Sodium Citrate, Sodium Benzoate, Sodium Metabisulfite, Methylparaben, Parfum (Fragrance), Benzyl Alcohol
